Skip to content
HCN Grants Est. 2026
No. HT942526MRPTSA · Defense Health Agency Contracting Activity - DHACA
Open

DoW Melanoma Research Program Team Science Award

Dealbreakers No cost share required Audit: not stated Reimbursement-only: not stated
Invitation only
“After submitting the required pre-application, investigators must receive an invitation to submit a full application.” — From the announcement

At a glance

This program funds hypothesis-driven, multidisciplinary melanoma research that is meant to advance science or patient care in the short term, and each project must involve at least two and up to three principal investigators. Eligible applicants include U.S. Department of War intramural and extramural organizations, including foreign and domestic, for-profit and nonprofit, and public or private entities. The program expects to fund about nine awards with a total cost cap of $2.1 million per award for up to 3 years, and cost sharing is not required. Applications must address at least one listed focus area, and studies involving non-melanoma skin cancers or, except for rare melanomas, established macrometastatic disease or developing treatments for macrometastatic disease are not allowed.

AI-generated summary — verify against the announcement

What it funds

  • Science and Technology and other Research and Development
  • Research & Discovery
  • Patients & People with Health Conditions
  • Biomedical & Disease Research
Official description from grants.gov

Summary: The fiscal year 2026 (FY26) Melanoma Research Program (MRP) Team Science Award supports a broad range of hypothesis-driven, multidisciplinary studies that have a short-term goal of advancing the state of the science in melanoma research and/or patient care. Team science is a synergistic effort that harnesses techniques, approaches and perspectives from multiple disciplines and/or therapeutic areas to address complex, multi-dimensional problems that will impact patient outcomes. Distinctive Features: · This funding mechanism requires multiple Principal Investigators (PIs). At least two and up to three PIs should partner to jointly design and execute a single research project ; multi-institutional partnerships are encouraged. If recommended for funding, each PI will be named on separate awards to the recipient organization(s). · Consumer Collaboration Option: Investigators are encouraged, but not required, to form collaborative relationships with the melanoma consumer community to maximize the impact and translatability of the research for the benefit of the intended community(ies). · After submitting the required pre-application, investigators must receive an invitation to submit a full application . Only the Initiating PI will submit a pre-application. All PIs must submit full applications. The Partnering PI(s)’s application is an abbreviated package specific to their proposed research effort.

Who can apply

  • Unrestricted
Geographic restriction None found in the announcement — likely nationwide